Sara Jane Ward, PhD
Adjunct Instructor
Contact
Sara Jane Ward, PhD
Adjunct Instructor
Education
PhD, Neuroscience, Wake Forest University School of Medicine, Winston-Salem, NC - 2004
BA, Psychology, University of Connecticut, Storrs, CT - 1997
Publications
- KLS-13019, a Novel Structural Analogue of Cannabidiol and GPR55 Receptor Antagonist, Prevents and Reverses Chemotherapy-Induced Peripheral Neuropathy in Rats
- Single and Combined Effects of Cannabigerol (CBG) and Cannabidiol (CBD) in Mouse Models of Oxaliplatin-Associated Mechanical Sensitivity, Opioid Antinociception, and Naloxone-Precipitated Opioid Withdrawal
- Knockdown siRNA Targeting GPR55 Reveals Significant Differences Between the Anti-inflammatory Actions of KLS-13019 and Cannabidiol
- Paclitaxel-Associated Mechanical Sensitivity and Neuroinflammation Are Sex-, Time-, and Site-Specific and Prevented through Cannabigerol Administration in C57Bl/6 Mice
- Epicutaneous Sensitization to the Phytocannabinoid β-Caryophyllene Induces Pruritic Inflammation
Research & Interest
Behavioral pharmacological effects of the cannabinoid, serotonin, & opioid receptor systems on neuropathic pain & neuroprotection, learning & memory, & addiction.
Biography
Dr. Sara Jane Ward is an Assistant Professor in the Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University.
She earned her PhD in neuroscience at Wake Forest University in Winston-Salem NC. Dr. Ward is currently working on several projects to elucidate the therapeutic potential of non-psychoactive cannabinoids, including studies supported by the National Institutes of Health and Department of Defense investigating the efficacy of cannabidiol for the treatment of peripheral and central neuropathic pain. Other projects include investigating the efficacy of cannabidiol and synthetic cannabinoids on a range of nervous system targets including stroke, traumatic brain injury, and addiction.
Teaching
Health Implications of Medicinal Cannabi
Conventional & Cannabinoid Therapy of Disease
Pathology Potentially Responsive to Cannabis